TELL ME MORE
ABOUT THIS CLINICAL TRIAL for LUPUS ERYTHEMATOSUS
This is a Placebo-controlled and Active-comparitor Study of a Biologic Investigational Medicine for Adults with Moderate to Severe Lupus Erythematosus
Clinical Trial for Systemic Lupus Erythematosus in Adults
Study Location(s): Evansville Indiana
Lupus is a chronic (long-term) disease that can cause inflammation and pain in any part of your body. It’s an autoimmune disease, which means that your immune system — the body system that usually fights infections — attacks healthy tissue instead. Lupus most commonly affects your skin, joints, and Internal organs, like your kidneys and heart. This lupus erythematosus in adults study evaluates an investigational suplemental medicine in combination wtih a JAK inhibitor compared to placebo in combination with the approved JAK inhibitor medicine in adults 18 – 65 years of age. Click here for more information on living with SLED.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimbursement up to $750 may be available.
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ACNE Trifarotene Cream used with and 0ral antibiotic to treat severe acne vulgaris | Evansville | Recruiting | 12+ | $600 | Request Info | |
| ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Owensboro | Recruiting | 6 - 17 | $1150 | Request Info | |
| ADHD A randomized, double-blind, multicenter, placebo-controlled study to evaluatate efficacy and safety of an investigational medicine in preschool-age children | Bowling Green Evansville Owensboro | Coming Soon | 4 - 5 | $400 | Request Info | |
| ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 65 | $500 | Request Info | |
| ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $800 | Request Info | |
| COMMON WARTS Efficacy, Safety and Tolerability Study in Children and Adults with Common Warts | Evansville | Coming Soon | 2+ | $350 | Request Info | |
| COVID-19 Safety and Eficacy Study of a Monoclonal Antibody Therapy for Patients with Mild to Moderate COVID-19 | Evansville Owensboro | Recruiting | 18+ | $3000 | Request Info | |
| DIABETES (T2DM) Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Recruiting | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
| ECZEMA An open-label expanded access study in adult and adolescent patients age 12+ with moderate-to-severe Atopic Dermatitis (Eczema) | Evansville | Coming Soon | 12+ | $50 per visit | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| IBS- CONSTIPATION An efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Paused | 6 - 17 | $350 | Request Info | |
| INFANT FORMULA Comparison Study | BowlingGreen Evansville Owensboro | Recruiting | Newborns | Variable up to $1700, + formula and diapers | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| INFANT VACCINE Comparison Study between two pneumococcal vaccines | Bowling Green | Coming Soon | Newborns | Variable up to $400 | Request Info | |
| LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Recruiting | 18 - 65 | $750 | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Recruiting | 6 - 17 | $200/$350 | Request Info | |
| MOLLUSCUM (Water Warts) An efficacy and safety, placebo-controlled study for patients with molluscum contagiosum | BowlingGreen Owensboro Evansville | Recruiting | 6 MO+ (children and adults) | $645 | Request Info | |
| PRURITUS (CHRONIC ITCH) An efficacy and safety study for the treatment of chronic itch in adult subjects with atopic dermatitis | Owensboro | Coming Soon | 18 - 75 | $600 | Request Info | |
| RHEUMATOID ARTHRITIS (RA) This is a comparison study to evaluate an investigational medicine for Rheumatoid Arthritis in adults with moderately or severely active disease and who have had inadequate response to conventional synthetic or biologic Disease Modifying Anti-rheumatic Drugs (DMARDs). | Evansville | Coming Soon | 18+ | Up to $1750 | Request Info | |